|国家科技期刊平台
首页|期刊导航|儿科药学杂志|儿童中成药精细化管理系统的建立与运用

儿童中成药精细化管理系统的建立与运用OACSTPCD

Establishment and Application of Refined Management System for Chinese Patent Medicine in Children

中文摘要英文摘要

目的:加强中成药处方的前置审核,促进儿童合理使用中成药.方法:借助前置审方系统开发中成药处方维护规则库,对中成药的用法用量、疗程、毒性成分、联合用药等项目进行精细化设置,即儿童中成药精细化管理系统;统计系统运行前后中成药的使用金额、门诊均次药费及抽样点评中的处方合格率,评价运行效果.结果:儿童中成药精细化管理系统运行后,重复给药和用法用量不适宜的中成药处方显著减少,中成药处方抽样点评合格率由88.13%提高至96.25%;中成药人均使用费用由18.71元降至16.29元,门诊均次药费由60.75元降至53.99元.结论:对中成药处方进行精细化管理可以促进临床合理用药,改善药事管理指标,同时提高医院信息化管理水平.

Objective:To strengthen the pre-review of Chinese patent medicine and promote the rational use of Chinese patent medicine in children.Methods:The prescription maintenance rule base of Chinese patent medicine was developed with the help of the prescription pre-review system,the usage and dosage,course of treatment,toxic components,drug combination and other items were finely set,the refined management system of Chinese patent medicine for children was constructed.Consumption sum of Chinese patent medicine,average outpatient drug cost and qualified rate of sample reviews before and after the implementation of the system were counted to evaluate the implementation effect.Results:After the implementation of refined management system of Chinese patent medicine for children,the prescription of Chinese patent medicine with repeated administration and inappropriate dosage decreased significantly,the qualified rate of sample reviews increased from 88.13%to 96.25%.The per capita use cost of Chinese patent medicine decreased from 18.71 RMB to 16.29 RMB,and the average outpatient drug cost decreased from 60.75 RMB to 53.99 RMB.Conclusion:The refined management system of Chinese patent medicine could promote rational clinical drug use,improve the pharmaceutical management indicators,and improve the level of hospital information management.

曹丹丹;王燕;李敏;洪远;周丹丽

江南大学附属儿童医院,江苏无锡 214002

药学

处方前置审核中成药精细化管理合理用药

pre-review systemChinese patent medicinerefined managementrational drug use

《儿科药学杂志》 2024 (008)

31-36 / 6

无锡市卫生健康委科技成果与适宜技术项目,编号T202012.

10.13407/j.cnki.jpp.1672-108X.2024.08.008

评论